Legal & General Group’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-916
Closed -$20.7K 3467
2024
Q1
$20.7K Hold
916
﹤0.01% 2947
2023
Q4
$11.9K Hold
916
﹤0.01% 3199
2023
Q3
$18.4K Sell
916
-5,303
-85% -$107K ﹤0.01% 3067
2023
Q2
$167K Buy
6,219
+2,985
+92% +$80.1K ﹤0.01% 2772
2023
Q1
$189K Buy
3,234
+179
+6% +$10.4K ﹤0.01% 2608
2022
Q4
$156K Buy
3,055
+534
+21% +$27.3K ﹤0.01% 2700
2022
Q3
$207K Buy
2,521
+283
+13% +$23.2K ﹤0.01% 2617
2022
Q2
$151K Buy
2,238
+115
+5% +$7.76K ﹤0.01% 2736
2022
Q1
$234K Hold
2,123
﹤0.01% 2616
2021
Q4
$205K Buy
2,123
+120
+6% +$11.6K ﹤0.01% 2716
2021
Q3
$175K Buy
2,003
+781
+64% +$68.2K ﹤0.01% 2727
2021
Q2
$190K Sell
1,222
-56
-4% -$8.71K ﹤0.01% 2545
2021
Q1
$202K Buy
1,278
+12
+0.9% +$1.9K ﹤0.01% 2454
2020
Q4
$294K Sell
1,266
-8
-0.6% -$1.86K ﹤0.01% 2350
2020
Q3
$279K Sell
1,274
-205
-14% -$44.9K ﹤0.01% 2303
2020
Q2
$420K Buy
1,479
+598
+68% +$170K ﹤0.01% 2209
2020
Q1
$254K Sell
881
-186
-17% -$53.6K ﹤0.01% 2233
2019
Q4
$306K Buy
1,067
+183
+21% +$52.5K ﹤0.01% 2312
2019
Q3
$128K Buy
884
+94
+12% +$13.6K ﹤0.01% 2453
2019
Q2
$71K Buy
790
+116
+17% +$10.4K ﹤0.01% 2649
2019
Q1
$59K Hold
674
﹤0.01% 2652
2018
Q4
$95K Buy
674
+160
+31% +$22.6K ﹤0.01% 2476
2018
Q3
$131K Hold
514
﹤0.01% 2434
2018
Q2
$131K Buy
514
+86
+20% +$21.9K ﹤0.01% 2412
2018
Q1
$86K Sell
428
-193
-31% -$38.8K ﹤0.01% 2517
2017
Q4
$90K Hold
621
﹤0.01% 2631
2017
Q3
$102K Buy
621
+88
+17% +$14.5K ﹤0.01% 2636
2017
Q2
$73K Buy
533
+79
+17% +$10.8K ﹤0.01% 2773
2017
Q1
$88K Sell
454
-44
-9% -$8.53K ﹤0.01% 2610
2016
Q4
$70K Buy
498
+201
+68% +$28.3K ﹤0.01% 2754
2016
Q3
$43K Hold
297
﹤0.01% 2597
2016
Q2
$31K Buy
297
+134
+82% +$14K ﹤0.01% 2719
2016
Q1
$21K Hold
163
﹤0.01% 2663
2015
Q4
$33K Hold
163
﹤0.01% 2612
2015
Q3
$26K Hold
163
﹤0.01% 2676
2015
Q2
$63K Hold
163
﹤0.01% 2428
2015
Q1
$75K Hold
163
﹤0.01% 2229
2014
Q4
$90K Hold
163
﹤0.01% 2063
2014
Q3
$90K Buy
+163
New +$90K ﹤0.01% 1957